Gianella, Sara
Letendre, Scott L.
Iudicello, Jennifer
Franklin, Donald
Gaufin, Thaidra
Zhang, Yonglong
Porrachia, Magali
Vargas-Meneses, Milenka
Ellis, Ronald J.
Finkelman, Malcolm
Hoenigl, Martin
Funding for this research was provided by:
National Institute of Mental Health (PST-HN68)
Article History
Received: 26 December 2018
Revised: 15 May 2019
Accepted: 12 June 2019
First Online: 11 July 2019
Compliance with ethical standards
: The UCSD Human Research Protections Program approved the study protocol, consent, and all study-related procedures. All study participants provided voluntary, written informed consent before any study procedures were undertaken.
: MH received grant funding from Gilead. YZ and MF are employees of Associates of Cape Cod. All other authors declare no conflict of interest.
: Fungitell®, the FDA-cleared IVD kit used for the measurement of (1 → 3)-β-glucan in serum, does not have an indication for the diagnostic use of BG titers in CSF. The data presented here represents the research use only.